Armando Anido
2022
In 2022, Armando Anido earned a total compensation of $1.9M as Chairman of the Board and CEO at Zynerba Pharmaceuticals, a 15% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $284,331 |
|---|---|
| Option Awards | $368,467 |
| Salary | $633,000 |
| Stock Awards | $578,400 |
| Other | $17,204 |
| Total | $1,881,402 |
Anido received $633K in salary, accounting for 34% of the total pay in 2022.
Anido also received $284.3K in non-equity incentive plan, $368.5K in option awards, $578.4K in stock awards and $17.2K in other compensation.
Rankings
In 2022, Armando Anido's compensation ranked 1,860th out of 5,753 executives tracked by ExecPay. In other words, Anido earned more than 67.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,860 out of 5,753 | 68th |
Division Manufacturing | 979 out of 3,133 | 69th |
Major group Chemicals And Allied Products | 405 out of 1,419 | 72nd |
Industry group Drugs | 370 out of 1,320 | 72nd |
Industry Pharmaceutical Preparations | 265 out of 966 | 73rd |
Source: SEC filing on April 21, 2023.
Anido's colleagues
We found two more compensation records of executives who worked with Armando Anido at Zynerba Pharmaceuticals in 2022.
News
Zynerba Pharmaceuticals CEO Armando Anido's 2022 pay slips 15% to $1.9M
April 21, 2023
Zynerba Pharmaceuticals CEO Armando Anido's 2021 pay jumps 49% to $2.2M
April 25, 2022
Zynerba Pharmaceuticals CEO Armando Anido's 2020 pay rises 8% to $1.5M
April 21, 2021
Zynerba Pharmaceuticals CEO Armando Anido's 2019 pay falls 32% to $1.4M
April 23, 2020
Zynerba Pharmaceuticals CEO Armando Anido's 2018 pay slips 18% to $2M
April 25, 2019